Isorhamnetin
CAS 480-19-3
Isorhamnetin (CAS 480-19-3) is a pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 18750.96 nM | 25 | - |
| - | Ki | 3437.2444444444445 nM | 9 | - |
| - | Potency | 33050.614285714284 nM | 5 | - |
| - | EC50 | 26.2 ug | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Isorhamnetin used for in pharmaceutical contexts?
Isorhamnetin (CAS 480-19-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Isorhamnetin?
No adverse-event association or SIDER side-effect rows are rendered for Isorhamnetin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Isorhamnetin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Isorhamnetin with EU status "permitted".
What clinical phase is Isorhamnetin in?
No phase 1-4 clinical development badge is rendered for Isorhamnetin because the matched compound identifier rows do not contain a max-phase value.